International Journal of Cardiology
Volume 129, Issue 3 , Pages 394-398 , 13 October 2008

Low utilisation of cardiovascular risk reducing therapy in patients with acute coronary syndromes and non-obstructive coronary artery disease

Received 17 September 2007 ,Accepted 11 December 2007.

References 

  1. Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293:477–484
  2. Zimmerman FH, Cameron A, Fisher LD, Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (coronary artery surgery study registry). J Am Coll Cardiol. 1995;26:654–661
  3. Kemp HG, Kronmal RA, Vlietstra RE, Frye RL. Seven-year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol. 1986;7:479–483
  4. Lichtlen PR, Bargheer K, Wenzlaff P. Long-term prognosis of patients with angina-like chest pain and normal coronary angiographic findings. J Am Coll Cardiol. 1995;25:1013–1018
  5. Diver DJ, Bier JD, Ferreira PE, et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol. 1994;74:531–537
  6. Bugiardini R, Manfrini O, De Ferrari G. Unanswered questions for management of acute coronary syndrome. Risk stratification of patients with minimal disease or normal findings on coronary angiogram. Arch Intern Med. 2006;166:1391–1395
  7. Maurin T, Zeller M, Cottin Y, et al. Long-term prognosis of patients with acute coronary syndrome and moderate coronary artery stenosis. Cardiology. 2003;99:90–95
  8. Redfern J, Ellis E, Briffa T, Freedman SB. Modular prevention of heart disease following acute coronary syndrome (ACS). BMC Cardiovasc Disord. 2006;6:26
  9. Commonwealth Department of Health and Aging . In: Australian refined diagnosis related groups. Canberra: Commonwealth of Australia; 1998;Version 4.1 (vol. 1)
  10. El Assaad MA, Topouchian J, Asmar RG. Evaluation of two devices for self measurement of blood pressure according to the international protocol: the Omron MS-I and the Omron 705IT. Blood Press Monit. 2003;8:127–133
  11. Cunnington AJ, Hormbrey P. Breath analysis to detect recent exposure to carbon monoxide. Postgrad Med J. 2002;78:233–237
  12. Booth M. Assessment of physical activity: an international perspective. Res Q Exerc Sport. 2000;71:S114–S120
  13. Roe MT, Harrington RA, Prosper DM, et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease. Circulation. 2000;102:1101–1106
  14. Germing A, Lindstaedt M, Ulrich S, et al. Normal angiogram in acute coronary syndrome-preangiographic risk stratification, angiographic findings and follow-up. Int J Cardiol. 2005;99:19–23
  15. Rigatelli G, Rigatelli G, Rossi P, Docali G. Normal angiogram in acute coronary syndromes: the underestimated role of alternative substrates of myocardial ischemia. Int J Cardiovasc Imaging. 2004;20:471–475
  16. Acute Coronary Syndrome Guidelines Working Group . Guidelines for the management of acute coronary syndromes 2006. Med J Aust. 2006;184:S9–S29
  17. Nissen SE, Nicholls SJ, Sipahi I, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID Trial. JAMA. 2006;295:1556–1565
  18. Pizzi C, Manfrini O, Fontana F, Bugiardini R. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme a reductase in cardiac Syndrome X: role of superoxide dismutase activity. Circulation. 2004;109:53–58
  19. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2002;40:1366–1374
  20. Ambrose JA, Winters SL, Arora RR, et al. Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol. 1986;7:472–478
  21. Haft JI, Haik BJ, Goldstein JE, Brodyn NE. Development of significant coronary artery lesions in areas of minimal disease: a common mechanism for coronary disease progression. Chest. 1988;94:731–736
  22. MacAlpin RN. Cardiac arrest and sudden unexpected death in variant angina: complications of coronary spasm that can occur in the absence of severe organic coronary stenosis. Am Heart J. 1993;125:1011–1017
  23. Akdemir R, Gunduz H, Emiroglu Y, Uyan C. Myocardial bridging as a cause of acute myocardial infarction: a case report. BMC Cardiovasc Disord. 2002;2:15
  24. Erbel R, Heusch G. Coronary microembolization. J Am Coll Cardiol. 2000;36:22–24
  25. Wang K, Asinger RW, Marriot HJL. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med. 2003;349:2128–2135
  26. Beltrame JF, Turner SP, Leslie SL, Solomon P, Freedman SB, Horowitz JD. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon. J Am Coll Cardiol. 2004;44:57–62
  27. Topol EJ, Nissen SE. Our preoccupation with coronary lumenology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 1995;92:2333–2342
  28. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111:3481–3488

PII: S0167-5273(08)00004-1

doi: 10.1016/j.ijcard.2007.12.023

International Journal of Cardiology
Volume 129, Issue 3 , Pages 394-398 , 13 October 2008